Is Kymera public?
Kymera Therapeutics has successfully priced a public offering of $250. The offering includes both common stock and pre-funded warrants, indicating strong investor interest and flexibility in financing options. Kymera Therapeutics Announces Closing of Initial Public Offering with Exercise in Full of the Underwriters’ Option to Purchase Additional Shares and Concurrent Private Placement. WATERTOWN, Mass. Aug. GLOBE NEWSWIRE) — Kymera Therapeutics, Inc.